A detailed history of Royal Bank Of Canada transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 13,414 shares of SGHT stock, worth $35,815. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,414
Previous 11,811 13.57%
Holding current value
$35,815
Previous $78,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.49 - $8.31 $8,800 - $13,320
1,603 Added 13.57%
13,414 $84,000
Q2 2024

Aug 14, 2024

BUY
$5.13 - $7.15 $18,811 - $26,219
3,667 Added 45.03%
11,811 $78,000
Q1 2024

Nov 05, 2024

SELL
$4.02 - $5.89 $14,741 - $21,598
-3,667 Reduced 31.05%
8,144 $43,000
Q1 2024

May 15, 2024

SELL
$4.02 - $5.89 $18,471 - $27,064
-4,595 Reduced 36.07%
8,144 $43,000
Q4 2023

Feb 14, 2024

SELL
$1.29 - $5.86 $9,198 - $41,787
-7,131 Reduced 35.89%
12,739 $65,000
Q3 2023

Nov 14, 2023

SELL
$2.88 - $8.8 $77,777 - $237,652
-27,006 Reduced 57.61%
19,870 $66,000
Q2 2023

Aug 14, 2023

BUY
$7.46 - $10.67 $3,633 - $5,196
487 Added 1.05%
46,876 $388,000
Q1 2023

May 15, 2023

SELL
$8.44 - $13.35 $64,616 - $102,207
-7,656 Reduced 14.17%
46,389 $405,000
Q4 2022

Feb 14, 2023

SELL
$5.58 - $13.94 $7,633 - $19,069
-1,368 Reduced 2.47%
54,045 $659,000
Q3 2022

Nov 14, 2022

BUY
$6.1 - $11.41 $860 - $1,608
141 Added 0.26%
55,413 $352,000
Q2 2022

Aug 15, 2022

SELL
$6.61 - $11.99 $8,269 - $14,999
-1,251 Reduced 2.21%
55,272 $497,000
Q1 2022

May 16, 2022

BUY
$11.56 - $17.9 $623,384 - $965,275
53,926 Added 2076.47%
56,523 $654,000
Q4 2021

Feb 14, 2022

BUY
$17.36 - $27.36 $3,906 - $6,156
225 Added 9.49%
2,597 $46,000
Q3 2021

Nov 15, 2021

BUY
$22.34 - $39.1 $52,990 - $92,745
2,372 New
2,372 $54,000

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $128M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.